PPT-How many suspected measles and rubella (MR) cases are adequately investigated? Epidemiological

3275 1447 678 70 5041 64 4249 101 314 359 1478 130 489 784 154 243 SC Suspected case Source Measles Elimination Surveillance System Integrated Surveillance Information System and country reports to FPLIMPAHO. Dr. Kimberly M. Thompson. 11. th. Annual Measles and Rubella Partners Meeting. September 19, 2012. Acknowledgments. World Health Organization (WHO) Contract PO 200470477 APW . Radboud. . Duintjer. . 11. th. Annual Meeting . Measles and Rubella Initiative. Washington, DC. Peter Strebel, WHO/EPI. The mission of the Decade of Vaccines is to extend, by 2020 and beyond, the full benefits of immunization to all people, regardless of where they are born, who they are, or where they live.". Panel 01502. Vicki Stambos. The 13. th. Global Measles and Rubella Laboratory Network Meeting, Geneva, Switzerland, 29. th. June to 1. st. July 2015. Vicki Stambos. Accelerating Progress Towards Measles and Rubella Control and Elimination Meeting. 11. th. Annual Meeting . Measles and Rubella Initiative. Washington, DC. Peter Strebel, WHO/EPI. The mission of the Decade of Vaccines is to extend, by 2020 and beyond, the full benefits of immunization to all people, regardless of where they are born, who they are, or where they live.". Dr. Kimberly M. Thompson. 11. th. Annual Measles and Rubella Partners Meeting. September 19, 2012. Acknowledgments. World Health Organization (WHO) Contract PO 200470477 APW . Radboud. . Duintjer. . M&RI Partners’ Meeting. Michael F Thomas, . Director Vaccine Implementation. September 2017, Washington DC. Page: . 1. Reach every child. . Measles and Rubella support in Gavi countries by end of 2016. 2020. . Summary of the . Findings . and Implementation Status . Dr Kaushik . Banerjee. M&RI Partners' Meeting. Washington DC. 7 September 2017. 1. Objectives . of . the Review. To provide a candid review of progress . Dr. Kimberly M. Thompson. 11. th. Annual Measles and Rubella Partners Meeting. September 19, 2012. Acknowledgments. World Health Organization (WHO) Contract PO 200470477 APW . Radboud. . Duintjer. . Definition of suspected measles and rubella case.  . Patient . with rash* with . two or more. of the following signs or symptoms:. fever, usually <38.5 ° C. conjunctivitis (non-purulent/hyperemic). Susan Reef, MD. , . and Joseph . P. Icenogle, PhD, colleagues. , . and other collaborators. Accelerating Progress towards Measles and Rubella Elimination,. 21-23 June 2016, Hotel Royal, Geneva. Background. Opening Comments & Perspectives. Dr. Suresh Jadhav. Executive Director. Serum Institute of India Pvt. Ltd.,. ssj@seruminstitute.com. . We, at Serum Institute of India Pvt. Ltd., feel proud of being a partner to PAHO / WHO in achieving what is designated to be a historical achievement in eradication of Measles & Rubella diseases from the Americas.. ─. 2012*. Source: Country reports * Data as of Week 31, 2012.. epidemiological week, Central America, 2019*. Source: ISIS, MESS, and country reports . . *Data as . of. . epidemiological. . week. 2019-48.. Source. : ISIS, MESS and country reports. | . *Data as of 1 May 2023.. N=. 18,897. 20,064. 18,971. 13,009. 13,308. 41,663. 91,950. 25,693. 9,318. 14,927. Text. In the last 10 years, there was a downward trend in the notification rate of suspected measles and rubella cases, reaching its lowest point in 2021: .